💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Genocea Biosciences, Inc. (GNCA)
« Back to company indexGNCA Chatter Timeline
Stock Ticker for GNCA
Most Active Tweeters for GNCA
| User | Tweets |
|---|---|
| @TheMarketsDaily | 3 |
| @ZolmaxNews | 2 |
| @ChartMill | 2 |
| @stocknewstimes | 2 |
| @PolackSki | 2 |
Recent Tweets for GNCA
 |
@ChartMill Based on estimates for the next 2 years, $GNCA will show a very strong growth in EPS: 31.38% on average per year.… https://t.co/g13qDfBd3X October 19th 2020, 8:10am |
 |
@StockTipRobot Complex analysis suggests you should buy Genocea Biosciences $GNCA #StockMarket October 19th 2020, 7:10am |
 |
@WatchlistN Genocea Biosciences $GNCA Stock Rating Lowered by Zacks Investment Research https://t.co/TLrfgZH7LX October 18th 2020, 2:10am |
 |
@TranscriptDaily Zacks Investment Research Lowers Genocea Biosciences $GNCA to Hold https://t.co/ampHgBPedM October 17th 2020, 6:10am |
 |
@dakotafinancial Genocea Biosciences, Inc. $GNCA Short Interest Down 46.0% in September https://t.co/BReRVrfvCG October 16th 2020, 3:10pm |
 |
@stocknewstimes Genocea Biosciences $GNCA Rating Lowered to Hold at Zacks Investment Research https://t.co/dVG0rSB9Pd October 16th 2020, 7:10am |
 |
@bbnsnews Zacks Investment Research Downgrades Genocea Biosciences $GNCA to Hold https://t.co/M3K9HNbDdi October 16th 2020, 7:10am |
|
@TranscriptDaily Genocea Biosciences, Inc. $GNCA Expected to Post Earnings of -$0.24 Per Share https://t.co/sdYyR3Sb7P October 15th 2020, 9:10am |
|
@stocknewstimes Genocea Biosciences, Inc. $GNCA Expected to Post Earnings of -$0.24 Per Share https://t.co/K0gTFMFyeh October 15th 2020, 9:10am |
 |
@TheMarketsDaily Genocea Biosciences, Inc. $GNCA Sees Large Drop in Short Interest https://t.co/ALLy0J2LMK October 15th 2020, 8:10am |
|
@TheMarketsDaily Genocea Biosciences $GNCA Downgraded by Zacks Investment Research to “Hold” https://t.co/Gx8ravNrYi October 15th 2020, 7:10am |
 |
@ZolmaxNews Genocea Biosciences $GNCA Rating Lowered to Hold at Zacks Investment Research https://t.co/35Yev0AGpY October 15th 2020, 7:10am |
|
@ZolmaxNews Genocea Biosciences $GNCA Trading 5.2% Higher https://t.co/YIFLSG9pUb October 15th 2020, 6:10am |
 |
@investor6969 Genocea Announces Upcoming Data Presentations at Virtual SITC 2020 $GNCA https://t.co/0T03WosZiQ via @benzinga October 14th 2020, 5:10pm |
 |
@otcdynamics $GNCA Genocea Announces Upcoming Data Presentations at Virtual SITC 2020 https://t.co/q1CABRxk4r October 14th 2020, 5:10pm |
 |
@PolackSki $GNCA GENOCEA ANNOUNCES UPCOMING DATA PRESENTATIONS AT VIRTUAL #SITC2020 https://t.co/xxGMmhajvE https://t.co/fT0BgxNzl3 October 14th 2020, 5:10pm |
 |
@stock_titan $GNCA Genocea Announces Upcoming Data Presentations at Virtual SITC 2020 https://t.co/ASgE6zT77W October 14th 2020, 5:10pm |
 |
@MojoTradin @Pharmdca @Pharmdca Have you looked into $GNCA October 14th 2020, 11:10am |
 |
@fireworkstrades RT @semodough: $SAVA had the biggest % increase and $GNCA the biggest % decrease in short interest as a percentage of float, at +9.9% and -… October 12th 2020, 11:10am |
 |
@semodough $SAVA had the biggest % increase and $GNCA the biggest % decrease in short interest as a percentage of float, at +9… https://t.co/kydSgPeK1E October 12th 2020, 11:10am |
|
@TheMarketsDaily Genocea Biosciences $GNCA Stock Passes Above 50 Day Moving Average of $2.34 https://t.co/YTPHLs2BbA October 10th 2020, 11:10am |
 |
@kylewdennis_fx Lost $27 trying to scalp a move on $GNCA https://t.co/1M6KStYIpO October 10th 2020, 3:10am |
 |
@Gambiste1 RT @chrismg88: $GNCA took a position today October 8th 2020, 7:10pm |
|
@chrismg88 $GNCA took a position today October 8th 2020, 6:10pm |
|
@PolackSki Genocea Oct.’20 Corp. Pres’n up. Slide 31/33, “Initiated (GEN-011) phase I/IIa clinical trial”. $GNCA #GEN011… https://t.co/ONezYQ4pEf October 7th 2020, 12:10pm |
|
@ChartMill $GNCA: The EPS is expected to grow by 31.38% on average over the next 2 years. This is a very strong growth.… https://t.co/rOqs9QmRPN October 6th 2020, 3:10am |
 |
@TickerReport Zacks Investment Research Downgrades Genocea Biosciences $GNCA to Hold https://t.co/IZBxZrU827 October 3rd 2020, 2:10am |
|
@PolackSki @GenoceaBio @TheChipClark Will Genocea be presenting new data at #SITC2020? Thanks! $GNCA October 2nd 2020, 10:10am |
 |
@username5858 $GNCA $OCGN picked up here for a swing October 1st 2020, 12:10pm |
|
@ba_0830 @TickerReport thanks all Zacks especially @ZacGalifianakis $GNCA https://t.co/wLCcH7tgJ1 September 30th 2020, 5:09pm |
 |
@AlexStarcevic $gnca is a buy $2.35 #Biotechnology September 30th 2020, 3:09pm |
 |
@SADIFAnalytics Will Genocea Biosciences Inc Perform Long Term? $GNCA https://t.co/wMccyI4y02 September 23rd 2020, 10:09am |
 |
@1stOncology #Genocea Announces #FDA Acceptance of #GEN011 #InvestigationalNewDrugApplication $GNCA https://t.co/9YEPtAhSBq September 23rd 2020, 6:09am |
 |
@HealthcareBeat Genocea on go with early-stage study of cancer candidate GEN-011 $GNCA https://t.co/oWwidNfuDk September 23rd 2020, 4:09am |
 |
@ConsumerFeed Traders Buy High Volume of Genocea Biosciences Call Options $GNCA https://t.co/owoTodAv8e September 23rd 2020, 1:09am |
 |
@MaisaCorp $GNCA the US Food and Drug Administration has accepted the company's investigational new drug application for GEN-0… https://t.co/QhiVyoMEh5 September 22nd 2020, 4:09pm |
 |
@AmericanBanking Genocea Biosciences $GNCA Shares Gap Up to $2.32 https://t.co/6O4UZMsvZW #stocks September 22nd 2020, 10:09am |
 |
@percent__b RT @Briefingcom: $GNCA: Genocea Biosciences: FDA has accepted its IND application for GEN-011 https://t.co/K66jaov9eD September 22nd 2020, 9:09am |
 |
@NewsQuantified $GNCA Announces FDA Acceptance of GEN-011 IND Application, stock shoots +6.46% https://t.co/AP4dkQIKjj September 22nd 2020, 9:09am |
 |
@Briefingcom $GNCA: Genocea Biosciences: FDA has accepted its IND application for GEN-011 https://t.co/K66jaov9eD September 22nd 2020, 9:09am |
 |
@TipRanks Genocea Up 5% On FDA Nod For Cancer Therapy Application; Street Sees 353% Upside https://t.co/WBDpoHLCJb $GNCA September 22nd 2020, 9:09am |
 |
@investor6969 Genocea Announces FDA Acceptance of GEN-011 IND Application $GNCA https://t.co/cayNDu5bko via @benzinga September 22nd 2020, 8:09am |
|
@HealthcareBeat FDA accepts Genocea' application to initiate early-stage study for GEN-011 in cancer $GNCA https://t.co/OUH6HbdLV8 September 22nd 2020, 7:09am |
 |
@MarketCurrents $GNCA - FDA accepts Genocea' application to initiate early-stage study for GEN-011 in cancer https://t.co/FFhmSlKv6B September 22nd 2020, 7:09am |
|
@otcdynamics $GNCA Genocea Announces FDA Acceptance of GEN-011 IND Application https://t.co/W6dSC4arYo September 22nd 2020, 7:09am |
 |
@HottestStockNow FDA Accepts $GNCA 's IND Application for GEN-011, an adoptive T cell therapy targeting neoantigens… https://t.co/440RaxgbL1 September 22nd 2020, 7:09am |
 |
@FlashAlert_me $GNCA [15s. delayed] filed form 8-K on September 22, 07:36:46: Item7.01: Regulation FD https://t.co/SjzVxQ0EWE September 22nd 2020, 7:09am |
 |
@EdgarInsider Filing for 8-K [Press/News Current Report] has been made with the SEC: $GNCA GENOCEA BIOSCIENCES, INC https://t.co/U4IRnejBGz September 22nd 2020, 7:09am |
 |
@sbwcws Genocea announces FDA acceptance of GEN-011 IND application $GNCA September 22nd 2020, 7:09am |
 |
@Stevema41911913 RT @HealthcareBeat: Genocea Announces FDA Acceptance of GEN-011 IND Application $GNCA https://t.co/S9sEIZgc50 September 22nd 2020, 7:09am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Make Better Decisions
Finding and Evaluating Generic and Branded Drug Market Entry Opportunities